|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 14-09-16 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 14-09-04 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Executive Committee: InterMune Inc
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 2002-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 2011-07-31 |
Company details: InterMune Inc
Other Biotechnology & Medical Research
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | +7.20% | -5.08% | +2.45% | 46.36B | |
| +2.19% | +11.71% | +385.81% | +632.13% | 37.88B | |
| +2.53% | +13.93% | +20.85% | -10.61% | 31.12B | |
| +1.65% | +3.61% | +9.98% | +55.42% | 30.61B | |
| -4.16% | -2.58% | +8.74% | +15.22% | 24.69B | |
| -0.32% | +12.96% | - | - | 16.25B | |
| +1.37% | +14.53% | +71.80% | +134.14% | 14.85B | |
| +1.00% | +10.30% | +13.31% | +22.84% | 13.58B | |
| +3.63% | +9.53% | +104.07% | +107.62% | 12.95B | |
| Average | +0.82% | +9.24% | +76.18% | +119.90% | 25.36B | |
| Weighted average by Cap. | +0.71% | +8.99% | +85.56% | +139.10% |
- Stock Market
- Stocks
- Stock
- Company InterMune Inc
Select your edition
All financial news and data tailored to specific country editions
